companiesandmarkets.com

Return to Report | Print

Premium Company Profile - Pain Therapeutics

http://www.companiesandmarkets.com/Summary-Company-Profile/premium-company-profile-pain-therapeutics-41378.asp

Report Summary

Introduction

Pain Therapeutics was initially focused on building a franchise of pain management products through partnering with the scientific and medical community. In 2006, Pain Therapeutics changed its focus from being a clinical research based company to becoming a fully integrated biopharmaceutical franchise through in-licensing activities.

Scope

  • Contains corporate strategy, value chain presence and SWOT Analysis
  • Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors
  • Includes information on suppliers/ partners, shareholding structure and key employees with biographies


    • Highlights

    Pain Therapeutics is focused on the development and commercialization of pharmaceutical products for pain management and hematology/oncology indications. The company has three investigational drug candidates in clinical programs, namely, Remoxy and PTI-202 which are in the Phase III and Phase I stage respectively.

    Pain Therapeutics derives its revenues mainly from program fee and collaboration related to the strategic alliance with King Pharmaceuticals for the development and commercialization of Remoxy and other abuse-resistant opioid painkillers.

    The company's total revenues increased significantly during the fiscal year 2006, from $5 million in 2005 to $54 million in 2006 The company's major contributor to the revenues during 2006 was program fee related to the strategic alliance with King Pharmaceuticals, which recorded revenues of $26 million during 2006.

    Reasons to Purchase

  • Access all the important information and analysis on the company in a single report
  • Understand company's strengths, weaknesses, opportunities and threats along with business strategy and value chain
  • Gain access to company's adjusted five year financial data along with key ratios and market capitalization

    • Table of Contents

    TABLE OF CONTENTS
    Overview 1
    Catalyst 1
    Summary 1
    Company Structure 7
    Company Overview and Key Facts 7
    Business Description 8
    Landmark Products and Services 9
    History 9
    Company Financials 11
    Stock Market Performance 11
    P&L 12
    Balance Sheet 14
    Cash Flow 14
    Business Segment Performance 15
    Products & Services 16
    Pipeline Products 16
    AC Forecast Product Sales 18
    Competitors and Strategic Business Relationships 20
    Key Competitors 20
    Key Suppliers 20
    Shareholding Structure 22
    Strategy 23
    Company View 23
    Corporate Strategy 25
    SWOT Analysis 27
    Overview 27
    Strengths 28
    Weaknesses 29
    Opportunities 30
    Threats 31
    Value Chain Analysis 32
    Overview 32
    Discovery and Product Development 32
    Scorecard 33
    Overview 33
    Scorecard Analysis 34
    Key Employees 35
    List of Key Employees 35
    Key Employee Biographies 36
    Financial and Operational Overview 41
    Financial and Operational Overview 41
    APPENDIX 43
    Ask the analyst 43
    Datamonitor consulting 43
    Disclaimer 43


    TABLE OF FIGURES
    Figure 1: Pain Therapeutics - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn) 13
    Figure 2: Pain Therapeutics - Key Strategic Revenues, 2006-2010 ($ Mn) 19


    TABLE OF TABLES
    Table 1: Pain Therapeutics - Key Facts 7
    Table 2: Pain Therapeutics - Year-End Share Price and Market Capitalization, 2002-2006 ($) 11
    Table 3: Pain Therapeutics - Key Events Impacting Share Price Performance 11
    Table 4: Pain Therapeutics - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn) 12
    Table 5: Pain Therapeutics - Operating Cost Ratio Analysis, 2002-2006 (% of total revenues) 14
    Table 6: Pain Therapeutics – Balance Sheet, 2002-2006 ($ Mn) 14
    Table 7: Pain Therapeutics – Cash Flow, 2002-2006 ($ Mn) 14
    Table 8: Pain Therapeutics - Revenue Breakdown, 2002-2006 ($ Mn) 15
    Table 9: Pain Therapeutics - In-house Pipeline Products 16
    Table 10: Pain Therapeutics - Collaboration Pipeline Products 17
    Table 11: Pain Therapeutics - Forecast Sales, 2006-2010 ($ Mn) 18
    Table 12: Pain Therapeutics – Key Competitors 20
    Table 13: Pain Therapeutics – Key Suppliers 21
    Table 14: Pain Therapeutics - Key Shareholders 22
    Table 15: Pain Therapeutics - SWOT Analysis Summary 27
    Table 16: Pain Therapeutics – Value Chain Analysis 32
    Table 17: Pain Therapeutics - Scorecard 33
    Table 18: Pain Therapeutics – Key Employees 35
    Table 19: Pain Therapeutics – Financial and Operational Overview 41